Categoría: Umbilical Cord
-
What Are Exosomes—and Why Do They Matter in Stem Cells?
Exosomes are tiny, bubble-like particles released by nearly every cell in our bodies—but they’re especially powerful when they come from mesenchymal stem cells, especially from the Stem Cell Institute’s Golden Cells™. Our team of scientists has developed our treatment protocols derived from the secretome (a collection of proteins and molecules that a cell secretes) of the umbilical cord…
-
Neil Riordan, PhD, Shows Video of Dividing UCB-Derived MSCs
—
por
*This blog has been updated since its original publication on 10/16/2019 Stem cell therapy is one of the leading treatments in regenerative medicine. Recently, our founder and board chairman, Neil Riordan, PA, Ph.D., shared a time-lapse video of stem cells splitting to be used in treatments. Viewers can watch as stem cells divide in Dr.…
-
Applied Stem Cell Therapy Expert, Neil Riordan, PhD, Authors “Cell Therapy for Liver Failure: A New Horizon” in Contemporary Liver Transplantation Medical Reference
—
por
en Adipose Stem Cells, Adult Stem Cells, Bone Marrow Stem Cells, COPD, Liver, Liver Transplantation, Liver Transplantation, medistem, Medistem Labs Panama, Mesenchymal Stem Cells, Neil Riordan PA PhD, News, Stem Cell Institute Panama, Stem Cell Research, Stem Cell Therapy, Stem Cells, Umbilical Cord, umbilical cord tissue stem cellsDALLAS-FORT WORTH, TEXAS (PRWEB) NOVEMBER 08, 2016 (Original Press Release on PRWeb) A new chapter by renowned applied stem cell therapy expert, Neil Riordan, PhD of the Riordan-McKenna Institute in Southlake, Texas; Medistem Labs Panama, and the Stem Cell Institute in Panama City, Panama, entitled, “Cell Therapy for Liver Failure: A New Horizon” is now…
-
Umbilical Cord Tissue Mesenchymal Stem Cells Best For Clinical Applications
A recent study concluded that umbilical cord tissue is the best source for clinically utilizable mesenchymal stem cells. Comparative Characterization of Cells from the Various Compartments of the Human Umbilical Cord Shows that the Wharton’s Jelly Compartment Provides the Best Source of Clinically Utilizable Mesenchymal Stem Cells. Arjunan Subramanian, Chui-Yee Fong, Arijit Biswas, Ariff Bongso…
-
After FDA Approval, Duchenne’s Muscular Dystrophy Patient Receives First Umbilical Cord Stem Cell Treatment in the United States
Ryan Benton, a 28 year-old Duchenne’s muscular dystrophy patient from Wichita, Kansas, received his first umbilical cord tissue-derived mesenchymal stem cell treatment yesterday at Asthma and Allergy Specialists of Wichita, KS following US FDA approval of his doctor’s application for a single patient, investigational new drug (IND) for compassionate use. Wichita, KS (PRWEB) September 10,…